ISRCTN46173989已完成未知
Combination drug treatment in moderate-to-severe essential hypertension
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with uncomplicated, moderate-to-severe essential hypertension which is not adequately controlled on triple therapy with amlodipine 5-10 mg once daily (o.d.), enalapril 10-20 mg b.d. and bendrofluazide 5 mg o.d., iv)
排除标准
- •Malignant or accelerated hypertension. Serum creatinine >60umol/L, ischaemic heart disease, cerebrovascular disease, impaired liver function, diabetes mellitus, pregnancy or risk of pregnancy, lactation, history of alcoholism, drug abuse or other problems likely to invalidate the informed consent.
研究者
相似试验
已完成
4 期
Combination drug therapy for fibromyalgia paiMusculoskeletal DiseasesOther soft tissue disorders, not elsewhere classifiedFibromyalgiaISRCTN20173707Queen's University (Canada)69
已完成
不适用
Combination therapy in rheumatoid arthritisRheumatoid arthritisISRCTN18445519Turku University Hospital (Finland)199
尚未招募
2 期
Comparison of outcomes of single drug therapy versus dual drug therapy in the treatment of hemodynamically significant PDACTRI/2024/05/066914Govind Choudhary
招募中
不适用
Concurrent Treatment for Patients with Severe Anorexia Nervosa and Post-Traumatic Stress Disorder: A Feasibility Studypost-traumatische stress-stoornisanorexiaanorexia nervosaNL-OMON56517Arkin (Amsterdam)11
已完成
不适用
A clinical study of combination drug against type 2 diabetes - Glubes combination tablets for patients poorly controlled with a-GI or Glinidetype2 diabetesJPRN-UMIN000007203Advanced Clinical Research Organization30